Patients' Perceptions of Information Received at the Start of Selective Serotonin-Reuptake Inhibitor Treatment: Implications for Community Pharmacy

被引:26
|
作者
van Geffen, Erica C. G. [1 ]
Kruijtbosch, Martine [2 ]
Egberts, Antoine C. G. [1 ,3 ]
Heerdink, Eibert R. [1 ]
van Hulten, Rolf [1 ]
机构
[1] Univ Utrecht, Div Pharmacoepidemiol & Pharmacotherapy, Utrecht Inst Pharmaceut Sci, Fac Sci, NL-3508 TB Utrecht, Netherlands
[2] SIR Inst Pharm Practice & Policy, Leiden, Netherlands
[3] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands
关键词
counseling; education; pharmacy; selective serotonin-reuptake inhibitors; ANTIDEPRESSANT TREATMENT; PHARMACEUTICAL CARE; DETERMINANTS; MEDICATION; DEPRESSION;
D O I
10.1345/aph.1L393
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Pharmacists are increasingly acknowledging their responsibility to inform and counsel patients. However, it is unclear how these tasks are implemented and whether patients' needs are being fulfilled. OBJECTIVE: To examine patients' perceptions of information received at the start of selective serotonin-re uptake inhibitor (SSRI) treatment, aiming to identify (1) information needs and (2) the potential role of the community pharmacist as information provider. METHODS: A qualitative descriptive study comprising semi-structured telephone interviews was carried out with patients who had recently started a new course of SSRI treatment. Patients were recruited through 6 Dutch community pharmacies. The interviews were guided by the following topics: type of information obtained, unmet information needs, preferred information provider, and the role of the pharmacist. RESULTS: Forty-one patients took part in an interview. Information needs varied widely among patients; overall, patients felt that they would benefit from information tailored to their needs. Many patients required more concrete and practical information on adverse effects and delayed onset of action than was provided. In addition, an explanation of the term dependency in the context of SSRI use and a discussion of the necessity for use and believed harms of long-term treatment were important to patients. Regardless of patients' needs, the role of the pharmacist was generally perceived as limited, and patients identified several pharmacy-related barriers to improved communication, including the timing of information (mainly restricted to first-time dispensing), lack of time and privacy, lack of empathy and a protocol-driven way of providing information, and inexperience of pharmacy technicians. CONCLUSIONS: Patients starting treatment with antidepressants may benefit from information tailored to their personal needs. Along with the prescribing physician, community pharmacists could have an important role in informing and counseling patients.
引用
收藏
页码:642 / 649
页数:8
相关论文
共 50 条
  • [1] Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment
    van Geffen, Erica C. G.
    van Hulten, Rolf
    Bouvy, Marcel L.
    Egberts, Antoine C. G.
    Heerdink, Eibert R.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (02) : 218 - 225
  • [2] Selective serotonin-reuptake inhibitor-induced movement disorders
    Gerber, PE
    Lynd, LD
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (06) : 692 - 698
  • [3] Selective serotonin-reuptake inhibitors for the treatment of hot flashes
    De Sloover Koch, Y
    Ernst, ME
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (7-8) : 1293 - 1296
  • [4] Duloxetine: A balanced and selective norepinephrine- and serotonin-reuptake inhibitor
    Westanmo, AD
    Gayken, J
    Haight, R
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (23) : 2481 - 2490
  • [5] Selective serotonin-reuptake inhibitors in the treatment of premature ejaculation
    Moreland, AJ
    Makela, EH
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1296 - 1301
  • [6] Hyponatraemia associated with the use of a selective serotonin-reuptake inhibitor in an older patient
    Schouten, WEM
    Sepers, JM
    AGE AND AGEING, 2001, 30 (01) : 94 - 94
  • [7] The effects of selective serotonin-reuptake inhibitor on visual evoked potential in rats
    Iwamura, Y
    Fujii, Y
    Kamei, C
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 (03) : 271 - 276
  • [8] Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression
    Nieuwstraten, CE
    Dolovich, LR
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1608 - 1613
  • [9] Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs
    Geldmacher, DS
    Lerner, AJ
    Voci, JM
    Noelker, EA
    Somple, LC
    Whitehouse, PJ
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 1997, 10 (03) : 99 - 104
  • [10] Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa
    van de Vijver, DAMC
    Roos, RAC
    Jansen, PAF
    Porsius, AJ
    de Boer, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (02) : 168 - 170